Metsera’s IPO Raises $275M to Show How Its Obesity Drugs Can Top Current GLP-1s
Drugs that activate the GLP-1 receptor transformed the treatment of obesity, but biotech company Metsera contends that limitations keep them ...
Drugs that activate the GLP-1 receptor transformed the treatment of obesity, but biotech company Metsera contends that limitations keep them ...
WASHINGTON — Robert F. Kennedy Jr., President Trump’s pick to lead the Department of Health and Human Services, doesn’t think ...
The U.S. Department of Health and Human Services unveiled 15 additional drugs chosen for the Medicare Drug Price Negotiation Program ...
After a lengthy investigation, South African regulators decided Vertex Pharmaceuticals has sufficiently provided access to its cystic fibrosis medications, ending ...
Credit: Pixabay/CC0 Public Domain The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular ...
Over decades, antibodies have established themselves as a key therapeutic modality for a wide range of diseases. But antibodies as ...
An antibody drug is only as good as its ability to connect to its target. Sometimes a mutation at the ...
A new study published today in Addiction suggests that Ozempic and similar medications may be able to help with treatment for ...
Credit: Pixabay/CC0 Public Domain A team of researchers at Kobe Gakuin University in Japan have genetically engineered insulin-fused proteins capable ...
The U.S. Center for Disease Control and Prevention (CDC) has issued a stark warning about counterfeit drugs sold illegally through ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.